Articles on Real Life Research

 

Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA).
Bousquet J, Van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR, Fokkens W, Lockey R, Meltzer EO, Mullol J, Naclerio RM, Price D, Simons FE, Vignola AM, Warner JO; European Academy of Allergy and Clinical Immunology (EAACI); Allergic Rhinitis and its Impact on Asthma (ARIA).
Allergy. 2003 Mar;58(3):192-7..

 

A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.
Price D, Shah S, Bhatia S, Bachert C, Berger W, Bousquet J, Carr W, Hellings P, Munzel U, Scadding G, Lieberman P.
J Investig Allergol Clin Immunol. 2013;23(7):495-503.

Study on drug costs associated with COPD prescription medicine in Denmark.
Jakobsen M, Anker N, Dollerup J, Poulsen PB, Lange P.
Clin Respir J. 2013 Oct;7(4):328-37. doi: 10.1111/crj.12010. Epub 2013 Jan 22.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
Rupert C M Jones, MD, Prof David Price, MD, Dermot Ryan, MD, Erika J Sims, PhD, Julie von Ziegenweidt, Laurence Mascarenhas, MSc, Anne Burden, MSc, David M G Halpin, DPhil, Robert Winter, MD, Prof Sue Hill, PhD, Matt Kearney, MRCGP, Kevin Holton, Anne Moger, MSc, Daryl Freeman, MRCGP, Alison Chisholm, MSc, Prof Eric D Bateman, PhD, on behalf of The Respiratory Effectiveness Group
The Lancet Respiratory Medicine. Volume 2, No. 4, p267–276, April 2014
Published Online: 12 February 2014  DOI: http://dx.doi.org/10.1016/S2213-2600(14)70008-6

The Global Asthma Report 2014

 

Exploring the role of quantitative feedback in inhaler technique education: a cluster-randomised, two-arm, parallel-group, repeated-measures study.
Toumas-Shehata M, Price D, Basheti IA, Bosnic-Anticevich S.
NPJ Prim Care Respir Med. 2014 Nov 13;24:14071. doi: 10.1038/npjpcrm.2014.71.

Interstitial lung disease: raising the index of suspicion in primary care.
Zibrak JD, Price D.
NPJ Prim Care Respir Med. 2014 Sep 11;24:14054. doi: 10.1038/npjpcrm.2014.54.

 

Current evidence and future research needs for FeNO measurement in respiratory diseases. 
Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O.
Respir Med. 2014 Jun;108(6):830-41. doi: 10.1016/j.rmed.2014.02.005. Epub 2014 Feb 15.

 

 

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Dirkje S Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem MC van Aalderen, Jonathan Grigg, Anne Burden, Elizabeth V Hillyer, Julie von Ziegenweidt, Gokul Go-palan, and David Price
Int J Chron Obstruct Pulmon Dis. 2014; 9: 1163–1186.
Published online 2014 Oct 17. doi:  10.2147/COPD.S68289

Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
Klimek L, Bousquet J, Price D.
Expert Opin Drug Saf. 2016 Jan;15(1):117-29. doi: 10.1517/14740338.2016.1122755.

Dymista®: Eine Klasse für sich* in der Behandlung der allergischen Rhinitis BACK
Dymista®: in a class of its own for the treatment of allergic rhinitis

Jean Bousquet, David Price, Massimo Triggiani, Ludger Klimek
Key Opinions in Medicine

Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States.
Nathan RA, Thompson PJ, Price D, Fabbri LM, Salvi S, González-Díaz S, Maspero JF, Moreno-Cantu JJ, Fish JE, Murphy K.
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):734-42.e5. doi: 10.1016/j.jaip.2015.04.013.

 

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Zuberbier T; MASK study group.
J Allergy Clin Immunol. 2016 Apr 23. pii: S0091-6749(16)30148-8. doi: 10.1016/j.jaci.2016.03.025.

 

Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
Chinedu Nwokoro, MBBChir, Hitesh Pandya, MD, Stephen Turner, MD, Prof Sandra Eldridge, PhD, Prof Christopher J Griffiths, MD, Tom Vulliamy, PhD, Prof David Price, MRCGP, Marek Sanak, PhD, John W Holloway, PhD, Rossa Brugha, BMBCh, Lee Koh, BSC, Iain Dickson, MRes, Clare Rutterford, MSc, Prof Jonathan Grigg, MD
Lancet Respiratory Medicine Volume 2, No. 10, p796–803, October 2014 http://dx.doi.org/10.1016/S2213-2600(14)70186-9

Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
Chinedu Nwokoro, MBBChir, Hitesh Pandya, MD, Stephen Turner, MD, Prof Sandra Eldridge, PhD, Prof Christopher J Griffiths, MD, Tom Vulliamy, PhD, Prof David Price, MRCGP, Marek Sanak, PhD, John W Holloway, PhD, Rossa Brugha, BMBCh, Lee Koh, BSC, Iain Dickson, MRes, Clare Rutterford, MSc, Prof Jonathan Grigg, MD
Lancet Respiratory Medicine Volume 2, No. 10, p796–803, October 2014 http://dx.doi.org/10.1016/S2213-2600(14)70186-9

 

 

Cost-effectiveness of the LABA/LAMA dual bronchodilator indacaterol/glycopyrronium in a Swedish healthcare setting.
Price D, Keininger D, Costa-Scharplatz M, Mezzi K, Dimova M, Asukai Y, Ställberg B.
Respir Med. 2014 Dec;108(12):1786-93. doi: 10.1016/j.rmed.2014.09.015.

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Dirkje S Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem MC van Aalderen, Jonathan Grigg, Anne Burden, Elizabeth V Hillyer, Julie von Ziegenweidt, Gokul Go-palan, and David Price
Int J Chron Obstruct Pulmon Dis. 2014; 9: 1163–1186.
Published online 2014 Oct 17. doi:  10.2147/COPD.S68289

Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.
D’Urzo T, Donohue JF, Price D, Miravitlles M, Kerwin E.
Expert Rev Respir Med. 2015 Oct;9(5):519-32. doi: 10.1586/17476348.2015.1081065.

Monitoring asthma in childhood: symptoms, exacerbations and quality of life.
Brand PL, Mäkelä MJ, Szefler SJ, Frischer T, Price D; ERS Task Force Monitoring Asthma in Children.
Eur Respir Rev. 2015 Jun;24(136):187-93. doi: 10.1183/16000617.00003614.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J17, Sullivan A, Wilson A, Price D.
Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.

Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.
Costa-Scharplatz M, Ställberg B, Goyal P, Asukai Y, Gruenberger JB, Price D.
Appl Health Econ Health Policy. 2015 Dec;13(6):637-45. doi: 10.1007/s40258-015-0193-2.

 

Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study
David Price, Amanda J Lee, Erika J Sims, Linda Kemp, Elizabeth V Hillyer, Alison Chisholm, Julie von Ziegenweidt & Angela Williams
Primary Care Respiratory Journal (2013) 22, 161–168
Published online: 04 March 2013.  doi:10.4104/pcrj.2013.00017

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC
International Journal of Chronic Obstructive Pulmonary Disease Volume 2015:10(1) Pages 2207—2217 DOI 10.2147/COPD.S91694

Controversies in COPD: Screening and Case Finding
Joan B. Soriano and David Price
ERS Monograph. DOI: 10.1183/2312508X.10018914

Blood and sputum biomarkers in COPD and asthma: a review
Paone, V. Leone, V. Conti, L. De Marchis, E. Ialleni, C. Graziani, M. Salducci, M. Ramaccia, G. Munafò
Eur Rev Med Pharmacol Sci 2016; 20 (4): 698-708

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM; RECORD Working Committee.
PLoS Med. 2015 Oct 6;12(10):e1001885. doi: 10.1371/journal.pmed.1001885.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J17, Sullivan A, Wilson A, Price D.
Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.

Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians
David Price, Brooke Harrow, Mark Small, James Pike and Victoria Higgins
World Allergy Organization Journal20158:26 DOI: 10.1186/s40413-015-0075-y

 

Asthma in Asia: Physician perspectives on control, inhaler use and patient communications.
Price D, David-Wang A, Cho SH, Ho JC, Jeong JW, Liam CK, Lin J, Muttalif AR, Perng DW, Tan TL, Yunus F, Neira G.
J Asthma. 2016 May 17:1-9.

A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
Anthony D’Urzo, James F Donohue, Peter Kardos, Marc Miravitlles, and David Price.
Expert Opin Pharmacother. 2015 Aug 13; 16(12): 1845–1860. doi:  10.1517/14656566.2015.1067682

 

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos PA, Camuzat T, Carlsen KH, Carr W, Cepeda Sarabia AM, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fink Wagner A, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grouse L, Guzmán MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, Koffi N’Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O’Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J.
Allergy. 2015 Nov;70(11):1372-92. doi: 10.1111/all.12686.

 

Letter from the Editor
David Price
European Respiratory and Pulmonary Diseases, 2015;1(1):13 DOI: 10.17925/ERPD.2015.01.01.13

Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON Study Group.
Respir Res. 2016 May 14;17(1):51. doi: 10.1186/s12931-016-0374-z.

 

Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
David Price, Monica Fletcher & Thys van der Molen
npj Primary Care Respiratory Medicine 24, Article number: 14009 (2014) doi:10.1038/npjpcrm.2014.9

Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H; LIAISON Study Group.
Respir Res. 2016 May 14;17(1):51. doi: 10.1186/s12931-016-0374-z.

The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines.
Nicholls SG, Quach P, von Elm E, Guttmann A, Moher D, Petersen I, Sørensen HT, Smeeth L, Langan SM, Benchimol EI.
PLoS One. 2015 May 12;10(5):e0125620. doi: 10.1371/journal.pone.0125620.

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM; RECORD Working Committee.
PLoS Med. 2015 Oct 6;12(10):e1001885. doi: 10.1371/journal.pmed.1001885.

Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG
Karin Lisspers, Pedro Teixeira, Coert Blom, Janwillem Kocks, Björn Ställberg, David Price & Niels Chavannes
npj Primary Care Respiratory Medicine 26, Article number: 16016 (2016) doi:10.1038/npjpcrm.2016.16

Detection of airflow limitation using a handheld spirometer in a primary care setting. 
Ching SM, Pang YK, Price D, Cheong AT, Lee PY, Irmi I, Faezah H, Ruhaini I, Chia YC. 
Respirology. 2014 Jul;19(5):689-93. doi: 10.1111/resp.12291. Epub 2014 Apr 7.